Forty percent of #patients with #gastriccancer are node negative, so
they have an unnecessarily extended lymph node dissection with a higher
rate of morbidity and mortality. Successful sentinel #lymphnode (SLN)
mapping may help to reduce the number of extended #lymphadenectomy.
Sentinel lymph node biopsy (SNB) is indicated in patients with T1 or T2
tumors; primary lesions < than 4 cm in diameter; and clinical N0
gastric
cancer. The injection method and selection of tracers for SLN mapping in
gastric cancer remain controversial. However, the use of dual tracer
and in cases with non-palpable lesions, the #submucosal marking method is
recommended. The identification rate and sensitivity are the highest
in time performing SLN biopsy after dye injection ≥15 min, the number of
SLNs ≥5 and application of the basin #dissection.
For more articles on BJSTR Journal please click here: https://biomedres.us/
For more Cancer Medical Articles on BJSTR
Clinical Aspects of Sentinel Lymph Node Biopsy in Gastric Cancer by Dezso Toth in BJSTR
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.